| 摘要 |
<p>The invention relates to compounds of general formula (I), wherein in particular, R1, R2, and R3 represent, each independently of each other, hydrogen, a halogen atom; a (C1C5)alkyl; a (C1C5)alkoxy; a trifluoromethyl or a group SR, wherein R represents a (C1C5)alkyl; R4, R5 represents a (C1C5)alkyl; an alkynyl with 3 to 5 carbon atoms; a (C3C5)cycloalkyl or an RaX(C1C2)alkyl group wherein Ra represents a (C1C3)alkyl and X represents O; R6 represents CHR7R8 wherein R7 represents a phenyl group which can be substituted by one or more radicals Z in position 3, 4 and 5, with Z representing a halogen; a (C1C5)alkyl; a (C1C5)alkylX or (C1C3)alkylX(C1C2)alkyl or X represents O; or a methylenedioxy group; and R8 represents a (C1C6)alkyl; a (C3C5)cycloalkyl(C1C3)alkyl; (C1C3)alkylX(C1C3)alkyle wherein X represents O. These compounds are suitable for CRF receptors.</p> |
